WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
$12.56
arrow_upward
+0.48%(+0.060) 1 日
10月16日, 16:00:00 GMT-4 · USD
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoWXXWY の上位の分析情報を生成しています...
始値
$12.29
高値
$12.56
安値
$12.20
時価総額
1984.28億
平均出来高
6.19万
取引量
11.08万
52 週高値
$14.80
52 週安値
$7.30
ベータ版
0.01
発行済株式数
20.58億
従業員数
1万
始値
$12.29
高値
$12.56
安値
$12.20
時価総額
1984.28億
平均出来高
6.19万
取引量
11.08万
52 週高値
$14.80
52 週安値
$7.30
ベータ版
0.01
発行済株式数
20.58億
従業員数
1万
ニュース記事
情報源: ウェブソース、ニュース パートナー
디지털투데이
·
17 時間前
S&P500が2割安ならビットコインは1万ドルも Bloomberg Intelligence分析
東奥日報社
·
1 日前
ＮＹ株反落、１７５ドル安｜全国のニュース｜Web東奥
BigGo ファイナンス
·
22 時間前
信用不安が世界のハイテク株を直撃 ナスダックは週間4.5%安と4カ月ぶりの大幅下落
プロフィール
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR について